Literature DB >> 21908523

A cohort study of children and young people with progressive neuromuscular disorders: clinical and demographic profiles and changing patterns of referral for palliative care.

Lorna K Fraser1, Anne-Marie Childs, Michael Miller, Jan Aldridge, Sue Manning, Patricia A McKinney, Roger C Parslow.   

Abstract

BACKGROUND: Progressive neuromuscular disease in children is life limiting and these children and young people would benefit from palliative care services, but data are limited on the number and demography of these children. AIM: To describe the clinical and demographic profile of children referred to a Children's hospice in the UK with progressive neuromuscular disease. SETTING/PARTICIPANTS: All children and young people with progressive neuromuscular disorders referred to Martin House Children's Hospice between 1987 and 2010.
DESIGN: Retrospective cohort study.
RESULTS: 300 children with progressive neuromuscular disease were referred to the hospice. Seventy percent (210) of these children had Duchenne Muscular Dystrophy, 22% (67) had Spinal Muscular Atrophy (34 with Type I) and 8% had other neuromuscular diseases. Numbers of referrals have not significantly increased over the last 15 years, although an increasing number come from a South Asian background (from 4% to 32%) and a higher number of children have conditions other than Duchenne Muscular Dystrophy. A total of 55.3% (166) of all referrals came from areas of the highest deprivation. Survival patterns varied by diagnostic group, but ethnicity and deprivation were not associated with survival in these children.
CONCLUSIONS: The profile of children with progressive neuromuscular conditions who were referred for palliative care has changed over the last 20 years, with a different spectrum of underlying diagnoses and a greater number from a South Asian background. The higher than expected proportion of children living in areas of high deprivation has been consistent over time.

Entities:  

Mesh:

Year:  2011        PMID: 21908523     DOI: 10.1177/0269216311419989

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

Review 1.  Children's complex care needs: a systematic concept analysis of multidisciplinary language.

Authors:  Maria Brenner; Claire Kidston; Carol Hilliard; Imelda Coyne; Jessica Eustace-Cook; Carmel Doyle; Thelma Begley; Michael J Barrett
Journal:  Eur J Pediatr       Date:  2018-08-08       Impact factor: 3.183

2.  Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.

Authors:  Jonathan Broomfield; Micki Hill; Michela Guglieri; Michael Crowther; Keith Abrams
Journal:  Neurology       Date:  2021-10-13       Impact factor: 9.910

3.  Numbers, characteristics, and medical complexity of children with life-limiting conditions reaching age of transition to adult care in England: a repeated cross-sectional study [version 1; peer review: 2 approved].

Authors:  Stuart Jarvi; Gerry Richardson; Kate Flemming; Lorna K Fraser
Journal:  NIHR Open Res       Date:  2022-04-08

4.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

5.  'Why does it happen like this?' Consulting with users and providers prior to an evaluation of services for children with life limiting conditions and their families.

Authors:  Anne Hunt; Erica Brown; Jane Coad; Sophie Staniszewska; Suzanne Hacking; Brigit Chesworth; Lizzie Chambers
Journal:  J Child Health Care       Date:  2013-11-21       Impact factor: 1.979

6.  The role of muscle ultrasound in helping the clinical diagnosis of muscle diseases.

Authors:  Hanan Helmy; Ahmed Aboumousa; Asmaa Abdelmagied; Aya Alsayyad; Sandra Ahmed Nasr
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.